The global pharmaceutical landscape is witnessing a seismic shift, and South China has emerged as an epicentre of this transformation. Recognising this dynamic, CPHI & PMEC China is set to host a monumental roadshow at Guangzhou’s PWTC Expo, from September 4-6, 2023. This special event is more than just a testament to China’s booming pharma industry; it is a reflection of the surging international demand for manufacturers hailing from South China, a region known for its impressive [six-day] visa-free access for over 60 nations.
The roadshow is an embodiment of China’s strategic positioning in the global pharmaceutical sector. Leveraging the Regional Comprehensive Economic Partnership agreement, it aligns with the ambitions of South China’s pharma companies to venture deeper into global markets. Guangdong, the country’s top-ranked R&D centre and home to its second-largest cohort of CDMOs, is particularly poised for rapid expansion of its pharmaceutical manufacturing base.
Noteworthy events like the Synthetic Biological Manufacturing Forum and the CXO Industry Innovation Conference exemplify the roadshow’s commitment to fostering innovation and strategic partnerships. Drawing inspiration from the multi-centre hubs of the United States, China is sculpting its own unique narrative in the pharmaceutical world, one that blends traditional and cutting-edge approaches.
